MRI coronary artery stenosis imaging will become "standard tool," researcher predicts.
This article was originally published in The Gray Sheet
Executive SummaryCORONARY ARTERY MRI WILL BECOME A "STANDARD TOOL" FOR DIAGNOSIS of arterial stenosis in the coming years, Bob Adelman, MD, Harvard Medical School, said in a speech at the annual meeting of the American Association for the Advancement of Science in Baltimore, Maryland on Feb. 12. Although several obstacles remain, magnetic resonance imaging has the potential to replace coronary angiography as the standard coronary artery imaging modality, Adelman maintained.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.